Company / AR per Share
Arbutus Biopharma Corp AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.01
FY2025
5-year range
$0.01 / $0.01
FY2021-FY2025
Trend
-46.3%
vs FY2024
Sector context
#109 of 113
Health Care
What the data says
Among 113 Health Care companies, Arbutus Biopharma Corp is in the bottom 4% for ar per share. AR per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2016 to $0.03 in FY2018.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -17.8%.
Declined from $0.01 to $0.01 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -6.5%
- 5-Year CAGR
- -17.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 113This company $0.01 Sector average $28.83
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, ar per share decreased 46.3% year-over-year.
- Ranks #109 out of 113 companies in the Health Care sector.
- Peak ar per share was recorded in FY2018.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -46.3% |
| FY2024 | $0.01 | +25.7% |
| FY2023 | $0.01 | +21.0% |
| FY2022 | $0.01 | -7.0% |
| FY2021 | $0.01 | -50.5% |
| FY2020 | $0.02 | -6.6% |
| FY2019 | $0.02 | -16.6% |
| FY2018 | $0.03 | +256.0% |
| FY2017 | $0.01 | +46.7% |
| FY2016 | $0.00 | -73.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026